At preset, the company is manufacturing pharmaceuticals products viz., tablets, capsules dry syrups and neutraceuticals at Roorkee and Ghatkesar units and marketing their products through out the India.

Expansion cum Diversification Project:

The Company is proposing to undertake expansion of marketing in new areas and planned to start a new unit for manufacturing of Pellets, DC Granules and API’s for captive consumption as well as export of surplus production. The proposed diversification project will be as export of surplus production. The proposed diversification project will be established as new company to be incorporated under the name and style “STRIDE LIFE SCIENCES PRIVATE LIMITED” with Mr.N.Surender and Mr.G.Hanumanth Rao as Promoters who are overseeing the works in relation to expansion and diversification and incidental acts thereon. The company has tied up with NRI owned firms in USA. For exporting of pellets and DC Granules.

Cost of the Expansion cum Diversification Project and means of Finance:

The total expansion cum diversification project outlay is estimated to be around Rs.40 Crores including margin for working capital which is proposed to be met by mobilizing resources in the form of share capital.

DEMAND, SUPPLY AND MARKETING

Due to increasing awareness of the public at large in health sector and also increase in the standard of living, more and more people are paying attention to take proper care of the health of family members. In fact, our own capital city has become very famous and is recognized as medical tourism spot which is gaining popularity not only in India but also from abroad. The economical and affordable pricing of the medical services has contributed its own share for this increase.

With the tremendous growth in the healthcare sector and medical facilities such as medical professionals, consulting clinics, nursing homes, corporate hospitals, diagnostic centers etc there is general spurt in the demand for the healthcare products including the products manufactured and to be manufactured by the company.

The promoters are making efforts so as to make available above quality products at competitive and affordable rates. The Company’s promoters being young and energetic will make intensive efforts for the success of unit.

Research & Development

Stride organics views Research and Development as a vital component of business strategy that will provide a long-term competitive advantage. Our R&D facility Advent has more than 15 diligent and committed scientists. Advent, located in Roorkee houses a range of state-of -the-art equipment for formulation development, working on different type of formulations such as tablets, liquid orals, capsules,topicalcreams,&dry syrups and other key products.

Our R&D hub covers an area of 3000 sq.ft and is fully equipped with modern amenities and technology for accessing reference material, environmental monitoring, data collection & analysis, record keeping and archiving. A separate Regulatory Affairs team works closely with
R&D, Manufacturing and Quality Assurance teams.